Elevance Health Inc stock (US0367521038): valuation focus after a quiet Nasdaq session

Elevance Health was quoted at USD 392.67 on Finanzen.net on 06/05/2026, while the stock remained listed on the NYSE under ELV. The Friday valuation slot can be filled from verified market data, but no same-day company release was provided in the search set.

Elevance Health Inc traded at USD 392.67 on 06/05/2026, and Finanzen.net showed the stock at EUR 336.80 in Germany the same day, keeping the company in view for U.S. investors on the NYSE and German readers alike. The available search results did not include a same-day company press release or filing, so this article stays centered on verified market data and the latest listed-company reference point from Finanzen.net.

As of: 06/05/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: ELV
• Sector/industry: Health care services and managed care
• Headquarters/country: Indianapolis, United States
• Core markets: United States
• Key revenue drivers: Commercial and government-sponsored health benefits, including managed care plans
• Home exchange/listing venue: NYSE (ELV)
• Trading currency: USD

Elevance Health Inc: core business model

Elevance Health provides managed health benefits and related administrative services, with its current business mix still anchored in U.S. health insurance and care-management operations. The company's revenue base is tied mainly to premium income and service fees from commercial, Medicare and Medicaid-related lines.

Valuation metrics and multiples for Elevance Health Inc

On Finanzen.net, Elevance Health was last shown at USD 392.67 on 06/05/2026, while the German-market reference price was EUR 336.80 on the same day. That dual-market snapshot gives readers a current reference point for the Friday valuation module, even though no fresh analyst note or earnings filing was part of the provided search set. The same page also identified the company by ISIN US0367521038, which matches the U.S. listing profile cited in the article header. According to Finanzen.net on 06/05/2026, the stock profile remains active and publicly traded, which supports a normal listed-company reading rather than any delisting scenario.

Conclusion

With no same-day earnings release or analyst update in the provided search results, the cleanest angle is the verified price snapshot and the companys continued listing in the United States. That makes the Friday valuation frame more useful than a headline-driven move narrative, especially for readers comparing the U.S. quote with the German reference price.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.